These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10333106)

  • 1. Dry Drops: a new preservative-free drug delivery system.
    Diestelhorst M; Grunthal S; Süverkrüp R
    Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):394-8. PubMed ID: 10333106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
    Jee D; Park SH; Kim MS; Kim EC
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability and safety of two new preservative-free tear film substitutes.
    Dinslage S; Stoffel W; Diestelhorst M; Krieglstein GK
    Cornea; 2002 May; 21(4):352-5. PubMed ID: 11973381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome.
    Brzheskiy VV; Efimova EL; Vorontsova TN; Alekseev VN; Gusarevich OG; Shaidurova KN; Ryabtseva AA; Andryukhina OM; Kamenskikh TG; Sumarokova ES; Miljudin ES; Egorov EA; Lebedev OI; Surov AV; Korol AR; Nasinnyk IO; Bezditko PA; Muzhychuk OP; Vygodin VA; Yani EV; Savchenko AY; Karger EM; Fedorkin ON; Mironov AN; Ostapenko V; Popeko NA; Skulachev VP; Skulachev MV
    Adv Ther; 2015 Dec; 32(12):1263-79. PubMed ID: 26660938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative bioavailability study of three conventional eye drops versus a single lyophilisate.
    Lux A; Maier S; Dinslage S; Süverkrüp R; Diestelhorst M
    Br J Ophthalmol; 2003 Apr; 87(4):436-40. PubMed ID: 12642306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a 0.9% sodium chloride ophthalmic solution on the ocular surface of symptomatic contact lens wearers.
    Barabino S; Rolando M; Camicione P; Chen W; Calabria G
    Can J Ophthalmol; 2005 Feb; 40(1):45-50. PubMed ID: 15825529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the clinical efficacy of preserved and preservative-free hydroxypropyl methylcellulose-dextran-containing eyedrops.
    Safarzadeh M; Azizzadeh P; Akbarshahi P
    J Optom; 2017; 10(4):258-264. PubMed ID: 27989693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness.
    Hommer A; Schmidl D; Kromus M; Bata AM; Fondi K; Werkmeister RM; Baar C; Schmetterer L; Garhöfer G
    Eur J Ophthalmol; 2018 Jul; 28(4):385-392. PubMed ID: 29592773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eye.
    Jacobi C; Kruse FE; Cursiefen C
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):598-603. PubMed ID: 22813209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ophthalmic lyophilisate carrier system (OLCS): development of a novel dosage form, freeze-drying technique, and in vitro quality control tests.
    Süverkrüp R; Grunthal S; Krasichkova O; Maier S; Weichselbaum A; Neff B; Diestelhorst M; Dinslage S; Lux A
    Eur J Pharm Biopharm; 2004 Mar; 57(2):269-77. PubMed ID: 15018984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of fluorescein from a new drug delivery system in human eyes.
    Steinfeld A; Lux A; Maier S; Süverkrüp R; Diestelhorst M
    Br J Ophthalmol; 2004 Jan; 88(1):48-53. PubMed ID: 14693772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Three conventional eye drops versus a single lyophilisate. A comparative bioavailability study].
    Lux A; Dinslage S; Süverkrüp R; Maier S; Diestelhorst M
    J Fr Ophtalmol; 2005 Feb; 28(2):185-9. PubMed ID: 15851952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension.
    Aptel F; Choudhry R; Stalmans I
    Curr Med Res Opin; 2016 Aug; 32(8):1457-63. PubMed ID: 27310103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of cellulosic ophthalmic inserts for treatment of dry eye.
    LaMotte J; Grossman E; Hersch J
    J Am Optom Assoc; 1985 Apr; 56(4):298-302. PubMed ID: 3989212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eye.
    Khanal S; Tomlinson A; Pearce EI; Simmons PA
    Cornea; 2007 Feb; 26(2):175-81. PubMed ID: 17251808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Tear Supplementation with 0.15% Preservative-Free Zinc-Hyaluronate on Ocular Surface Sensations in Patients with Dry Eye.
    Perényi K; Dienes L; Kornafeld A; Kovács B; Kiss HJ; Szepessy Z; Nagy ZZ; Barsi Á; Acosta MC; Gallar J; Kovács I
    J Ocul Pharmacol Ther; 2017; 33(6):487-492. PubMed ID: 28375789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyophilisates for drug delivery in ophthalmology: pharmacokinetics of fluorescein in the human anterior segment.
    Dinslage S; Diestelhorst M; Weichselbaum A; Süverkrüp R
    Br J Ophthalmol; 2002 Oct; 86(10):1114-7. PubMed ID: 12234889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patients.
    Renieri G; Führer K; Scheithe K; Lorenz K; Pfeiffer N; Thieme H
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):597-603. PubMed ID: 20977366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ocular tolerability of a new ophthalmic drug delivery system (NODS).
    Diestelhorst M; Krieglstein GK
    Int Ophthalmol; 1994; 18(1):1-4. PubMed ID: 7960409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.